SVB Securities started coverage on shares of Relay Therapeutics (NASDAQ:RLAY – Free Report) in a research note published on Tuesday, FlyOnTheWall reports. The firm issued an outperform rating on the stock. A number of other research firms have also weighed in on RLAY. Stifel Nicolaus dropped their price objective on shares of Relay Therapeutics from […]
Integral Health Asset Management LLC raised its position in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 23.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 770,000 shares of the company’s stock after acquiring an additional 145,000 shares […]
Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report)’s stock price was down 6.3% during trading on Tuesday . The company traded as low as $11.76 and last traded at $11.80. Approximately 251,106 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 1,413,617 shares. The stock had previously closed […]
Nextech Invest Ltd. boosted its holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 31.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 625,485 shares of the company’s stock after buying an additional 150,000 shares during the quarter. […]
Finepoint Capital LP cut its position in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Rating) by 3.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 517,287 shares of the biotechnology company’s stock after selling 19,614 shares during the period. […]